comparemela.com

Latest Breaking News On - Korean bioinformation center - Page 1 : comparemela.com

WANdisco grants industry leading LiveData Platform to fast-track high-volume genome analysis and Covid-19 research in South Korea

(0) SAN RAMON, Calif., March 17, 2021 /PRNewswire/ WANdisco, the LiveData company, announced today that it donated its LiveData Platform to help Korea Research Institute of Bioscience & Biotechnology conduct faster analysis in its efforts towards Covid-19 research. Using the automated data migration and replication platform, the institute has been able to replicate files between Hadoop-based big data clusters and Linux-based analysis clusters 13 times faster than before, and reduce analysis time by over 30 percent. In early 2020, WANdisco announced free access to their suite of cloud migration and big data tools for teams involved in research and developing potential treatments and cures for the Covid-19 pandemic. WANdisco provided its LiveData Platform along with technical resources to Korean Bioinformation Center (KOBIC) to assist the organization in enhancing its architecture, developing products, and introducing WANdisco s automated replication technology into KOBIC s work

Researchers introduce new tools for 3D research of cancer genome

Researchers introduce new tools for 3D research of cancer genome | (KAIST) A South Korean research team has built the world’s largest dataset and new browsing tools for the study of large-scale genomic rearrangements that could potentially cause cancer, the Korea Advanced Institute of Science and Technology said Monday. Researchers led by KAIST professor Jung In-kyung and Korean Bioinformation Center professor Lee Byung-wook have collected and processed around 230 billion raw reads including 220 Hi-C samples. Based on the data, the team has completed construction of 400 different 3D architectures of human genomes. Hi-C is a genome sequencing technique used to analyze the spatial genome organization of cells.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.